Rydapt
Midostaurin
- Concentración
- 25mg
- Fabricante
- Novartis Pharma
- Disponibilidad
- Disponible para obtener
Midostaurin 25mg — Capsule, 112's Strip
¿Necesita ayuda?
Nuestro equipo de soporte multilingüe puede ayudarle con disponibilidad, envío y pedidos.
Chatear por WhatsApp
Escanear para WeChat
Sobre este medicamento
Originator: Tauritmo, Rydapt by Novartis Pharmaceuticals · Manufacturer: Novartis Pharma. Indication & Dosage: Rydapt (Midostaurin), is a prescription medicine used to treat certain types of blood cell cancer (acute myeloid leukemia- AML) that is newly diagnosed FLT3 mutation positive as detected by an FDA-approved test. Midostaurin is also used to treat aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN), or mast cell leukemia(MCL). Rydapt is manufactured by Novartis Pharma Ltd. in Germany. Midostaurin has to take orally twice daily with food. Side Effects: The most common side effects of Midostaurin are: Febrile neutropenia (low level of white blood cells with fever), nausea , redness , pain , vomiting , headache , bruising , muscle or bone pain , nose bleeds, hyperglycemia (high blood sugar levels), upper respiratory infection, QT prolongation (abnormal electrocardiogram), diarrhea , constipation , fever . The above information comes from the Internet. Please consult with doctor for medical advice.
Indicaciones
Esta información es solo de referencia y no constituye consejo médico. Consulte siempre a un profesional de la salud calificado.
